Pharmacy Reverse Distribution Service
The Indian Health Service is conducting market research to identify capable Indian Small Business Economic Enterprises (ISBEEs) and Indian Economic Enterprises (IEEs) for pharmacy reverse distribution services. This effort follows the Buy Indian Act, which prioritizes Indian-owned entities meeting specific ownership and earnings criteria. The contractor will manage the inventory, packaging, and removal of expired medications at multiple service units within the Billings Area Indian Health Service. Work includes providing all labor, equipment, and materials for on-site services three times per year at designated Montana locations. The contractor must be a U.S. Drug Enforcement Administration (DEA) registered reverse distributor authorized to handle controlled substances and process manufacturer credits. This notice helps the agency determine if a set-aside is feasible for a contract period consisting of a base year and four option years beginning in July 2026. Supporting documents include a Statement of Work (SOW), the Sources Sought notice, and an IEE Representation Form, which outline technical standards such as the 120-day timeline for applying return credits and the 60-day requirement for providing certificates of receipt. This requirement involves on-site pharmaceutical reverse distribution at nine Montana locations. The contractor must be a DEA-registered reverse distributor responsible for labor, equipment, and transportation to process manufacturer credits. This is currently a market research phase to evaluate the feasibility of a set-aside. Provide comprehensive pharmaceutical reverse distribution for Billings Area pharmacy programs, including the secure removal and processing of expired products.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.
Contact and place of performance
Teri Kittson
USA
This is a Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. Pursuant to 48 CFR Part 326, Subpart 326.603-3 and IHM 5.5-6, Indian Health Service must use the negotiation authority of the Buy Indian Act, 25 U.S.C. 47, to give preference to Indian Economic Enterprises (IEE) whenever the use of that authority is authorized and practicable. The Gove...
View more